Page 1918 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

Index 1345

Intracranial pressure, 786–820 Intravascular hemochromogens, L
cerebral edema and mass effect, precipitation of, 1178 Labetalol, 363
794–795, 794t, 795f Intravascular volume, assessing, Laboratory studies and radiologic imaging,
brain tissue displacement and herniation 263–265 sepsis and, 567
syndromes, 795–797, 795ft, Intravascular volume contraction, 777 Lacosamide, for status epilepticus, 785
796ft, 797f Intravascular volume depletion, 1101 La Crosse virus (LACV), 673
examination of patient with suspected Intravenous fluid and electrolyte Lactic acidosis, 372, 498, 575, 725, 728, 828,
intracranial pressure elevation, management, in head injury, 835, 837, 968, 971, 1023, 1040
797–801, 798t, 799ft, 800f 1127–1128 acid-base balance and, 971
consideration of cerebral pressure Intravenous gamma globulin, use of, in brain damage and, 112
cerebral blood flow and perfusion, critically ill patient, 1252 Laminar flow, 405
https://kat.cr/user/tahir99/
791–792, 791f, 792f, 793f, 794 Intrinsic acute renal failure, 919–922, Large bowel obstruction, 1006
compartments and Monro-Kellie 920ft, 921t Laryngeal mask airway, intubating with,
doctrine, 786–788, 787f, 788f Intubation, 501–504, 502f, 503f 390, 392f
intracranial, 788–789, 789ft Invasive fungal infections, 617–621, Laryngotracheitis, 407
intracranial compliance, 789–791, 790f 619f, 620f fungal, 407
plateau waves, 794 Investigational care, for sickle cell Laryngotracheobronchitis, 685
general disease-specific comments, 816 disease, 914 Larynx, 404
fulminant hepatic failure, 817–818, Iodide-induced thyrotoxicosis, thyroid Lassa fever, 718, 738–739
817f disease and, 996 management of, 739
global cerebral hypoperfusion, Ionized hypocalcemia, 272–273 Lateral pharyngeal space infections, 681–683
818, 819f Ipratropium bromide, 499 Late sequelae of electrical injury, 1179–1180
hypertensive encephalopathy and Iron lung, 377 Lead-time bias, 94
eclampsia, 819, 820f Ischemia, 256 Learning, affirming, in critical care, 6
large supratentorial hemispheric Ischemic digits, 1247 Left ventricular contractility in critical
infarction, 816–817, 817f Ischemic edema, 794 illness, 273
septic encephalopathy, 818–819 Ischemic heart disease in rheumatology Left ventricular dysfunction, mechanisms and
traumatic brain injury, 816 patient, 1245 management of, 270–275, 271f, 272t
management of increased, 806–816 Isopropanol, 1210 Left ventricular end-diastolic pressure
algorithm approach to elevated, 816 Itraconazole, 623–624 (LVEDP), 315
general approach to patients with Left ventricular failure, 256
abnormal, 806–808, 807t, 808t J treatment of, 258
neuromedical, 808–813, 810t, Japanese encephalitis virus (JEV), 672 Left ventricular hypertrophy, 344
811f, 812t Jaundice, 998–1001 Left ventricular systolic contractility,
surgical, 813, 814–815f, 816 etiology of, 999, 999t decreased, 270–273, 271f, 272t
monitoring, 801–806 investigation of, 999, 999f Legal issues in critical care, 125–130
of abnormal, 803, 803t metabolism and measurement of bilirubin, decisional capacity and surrogate decision
adjunct brain modalities, 804–806, 998, 998f making, 126–127
805t nonobstructive, 999 informed consent and refusal, 126
cerebral autoregulation, 803–804 obstructive, 999 Legionella, 676
indications for, 801–802, 801t treatment of, 999–1001, 999t Lemierre syndrome, 598, 682–683, 682f
placing devices, 802–803, 802f Jet ventilation, 392 Length-of-stay, 40
Intracranial pressure monitoring Job burnout, 18 Leptospira, 676
head injury and, 1129–1130, 1130f Joint Commission, 11 Leukapheresis, 872
in intensive-care unit, 26 Jugular venous bulb oximetry, 1131, Leukemia. See also Acute leukemia
Intracranial subdural empyema, 686 1131f acute lymphoblastic, 867
Intracranial suppuration, 686–687 acute myelogenous, 867, 867t
Intramyocardial inflammatory response, K acute promyelocytic, 869–870
limitation of, 273 Kaposi’s sarcoma (KS), 636–637, central nervous system, 867–868
Intrathoracic blood volume, 264 1302 Leukocytoclastic vasculitis, 1294
Intrathoracic hemorrhage, 1158 Kawasaki disease, 922 Leukostasis, 878–879
Intravascular devices Kernohan notch phenomenon, Leukotriene inhibitors, 1279
infectious complications of, used in critical 1123 Leukotrienes, 500, 565
care, 588–593 Ketamine, 153, 504 Levetiracetam, for status epilepticus, 784
in intensive-care unit, 179–186 Ketoacidosis, 975 Levosimendan, 316
central internal jugular approach, acid-base balance and, 971 Levothyroxine overdose, thyroid disease and,
180, 181f Ketone bodies, 971 995
infectious complications of central Ketonemia, 975 Liberation from mechanical ventilation,
venous catheters, 182–183 Keystone ICU project, 36 535–541, 536t
infraclavicular subclavian approach, 180 Kidney Disease Improving Global Outcomes breaking the rules, 540–541, 541t
placement of central venous (KDIGO) group, 917 breathing without, 538–540, 538f,
catheters, 180 Kidney dysfunction in sepsis, 566 539f, 540f
posterior internal jugular approach, King-Denborough syndrome, 1062 expediting, 536–538, 537f
180, 181f King’s College Criteria, 1098 extubation, 540
ultrasound-guided placement, 180 Korsakoff-like amnesia, 669 strategies, 536
Intravascular foreign body retrieval, Kyasanur Forest disease, 738 LiDCO™, 247
225–226, 225f Kyphoscoliosis, 514 LiDCOplus, 248

Index.indd 1345 23-01-2015 15:33:52